Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6754
Rank
A$0.96 B
Marketcap
A$48.17
Share price
-0.08%
Change (1 day)
-3.66%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of June 2025 : A$0.22 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are A$0.22 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.22 B27.22%
2023-12-31A$0.17 B